WellDoc is a digital health company that develops and commercializes software-based solutions to improve the lives of people with chronic diseases. The company was founded in 2005 and is headquartered in Baltimore, Maryland. WellDoc's flagship product, BlueStar, is an FDA-cleared, prescription-only digital therapeutic that helps people with type 2 diabetes manage their condition. BlueStar provides personalized guidance and support to users, and has been shown to improve glycemic control and reduce healthcare costs. WellDoc is committed to advancing the field of digital health through research, innovation, and collaboration with healthcare providers, payers, and patients.